KELLEHER FINANCIAL ADVISORS

Position in MRNA — Moderna, Inc.

CIK 1507971 NEW YORK, NY

Position in MRNA

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$67,818

+$28,449 QoQ

Shares Held

1,335

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Healthcare · as of Mar 31, 2026

KELLEHER FINANCIAL ADVISORS holds $324,622 across 5 Biotechnology names. MRNA ranks #2 (20.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LENZ	LENZ Therapeutics, Inc.	17,023	$155,760
2	MRNA	Moderna, Inc. This page	1,335	$67,818
3	VRTX	Vertex Pharmaceuticals Inc / Ma	100	$44,654
4	NWBO	Northwest Biotherapeutics Inc	200,000	$42,000
5	NKTR	Nektar Therapeutics	200	$14,390

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,818	1,335	0.0%	Shares	Sole	2026-05-08
2025-12-31	$39,369	1,335	—	Shares	Sole	2026-01-20
No filing history on record for this holder in this stock.